ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 361667 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 361667; 2) Community: the network communities that were significantly associated with the response to NSC 361667; 3) Molecule: the relationships between components within communities and NSC 361667; 4) MDR: the compounds that were significantly associated with the NSC 361667.

NSC Compound Enrichment Correlation
NSC 166382 Null 0.0352383000003056 -0.11628307
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0352383000003056 -0.13928338
NSC 300289 Pinafide 0.0352383000003056 0.1376744
NSC 30915 Null 0.0352383000003056 0.0054543256
NSC 313681 Oxiperomide(USAN) 0.0352383000003056 0.11661844
NSC 33570 Null 0.0352383000003056 0.015131711
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0352383000003056 -0.10929594
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0352383000003056 -0.12276431
NSC 52426 Null 0.0352383000003058 -0.031338739
NSC 603071 Aminocamptothecin 0.0352383000003058 0.22107131
Total:81  Current:54    [First] [Prev] [Next] [Last]